Patients facing a rare disease diagnosis often find that participation in a clinical trial is the only course of treatment available to them. Selecting the right clinical trial payment option to reimburse patients for their participation is critical to improving access, enrollment, and retention in rare disease clinical trials.
With a greater understanding of the challenges facing patients, caregivers, and physicians, researchers can better structure Alzheimer’s disease studies to minimize barriers and improve participation. By providing direct support to participants from enrollment through the end of a clinical trial, logistics management companies establish and maintain a sense of trust between participants, caregivers, and site …
Clinical Matters: Recruiting and Retaining Alzheimer’s Patients for Clinical Trials Read More »
Patient Payments: Frequently Asked Questions Do your clinical trial patients need stipends, reimbursements, or a combination of payment types? Not sure? Many study teams are unsure about the different types of patient payments or how to decide which ones are appropriate for their study. Multiple payment options and country-specific requirements can seem overwhelming to a …
Do You Know Which Patient Payment Method is Right for Your Clinical Trial? Read More »
The COVID-19 pandemic created a “new normal” for clinical trial operations. The changes left many in the life sciences industry scrambling. However, Clincierge’s dedication to their patient-centric mission provided safety, stability, and continuity for patients and sponsors during an unprecedented time. Customized Support to Improve Your Study Performance At the start of each study, Clincierge …
Personalized Clinical Trial Support During COVID-19 Read More »
View the results of our recent research to explore how effective patient support strategies can reduce barriers, increase retention, and improve outcomes in rare disease clinical trials in our latest eBook.
